- cafead   Jun 22, 2022 at 12:02: AM
via Bristol Myers Squibb, Pfizer and Merck will face extreme patent cliff exposure later in this decade. But those companies also have the financial flexibility to perform mergers and acquisitions to overcome the anticipated losses.
article source
article source